No other significant associations with all-cause mortality, breast cancer-specific mortality, and breast cancer recurrence were observed for IGFBP3, IGF1/IGFBP3 ratio, insulin, and C-peptide. This evidence concerns the gene IGF1 and breast carcinoma.